Chad Cowan insider trades
Open-market stock purchases and sales by Chad Cowan, Chief Scientific Officer at Century Therapeutics, Inc, from SEC Form 4 filings since Oct 1, 2024.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +122%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | IPSC Century Therapeutics, Inc | Sold (not open market) | $802 |
| Apr 1, 2026 | IPSC Century Therapeutics, Inc | Sold (not open market) | $3K |
| Mar 11, 2026 | IPSC Century Therapeutics, Inc | Sold (not open market) | $3.9K |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc | Bought (not open market) | — |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc | Bought (not open market) | — |
| Jan 2, 2026 | IPSC Century Therapeutics, Inc | Sold (not open market) | $1.6K |
| Dec 22, 2025 | IPSC Century Therapeutics, Inc | Bought | $49.3K |
| Nov 20, 2025 | IPSC Century Therapeutics, Inc | Sold | $2.7K |
Companies traded
- IPSC Century Therapeutics, Inc: 1 buy, 1 sale, last Jun 11, 2026